ACT Biotech, Inc.

After recently raising a Series B funding of $32m from Chinese investors, EOC Pharma is planning to expand its team in clinical development, regulatory affairs and CMC (chemistry, manufacturing, and c

SEOUL - LSK BioPharma Inc. (LSKB) has completed a Phase IIa clinical trial for its gastric cancer therapy apatinib, a vascular endothelial growth factor receptor-2, or VEGFR-2, inhibitor, in the U

By Gemma Collier and Ian Haydock Eddingpharm International Holdings Ltd. has paid just €2 million upfront for the drug, which had positive Phase IIa results in May 2011. The company has gained ri

IN VITRO DIAGNOSTICS Alliances NovaMedica LLC Venter Pharma SL Russian specialty pharmaco NovaMedica LLC received exclusive rights to commercialize Spanish firm Venter Pharma SL ’s lactose into